Vaccination of patients with renal cell cancer with dendritic cell/tumor fusions and GM-CSF [granulocyte macrophage colony stimulating factors].
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dendritic cell vaccines (Primary) ; Granulocyte macrophage colony stimulating factor (Primary)
- Indications Renal cancer
- Focus Adverse reactions; Pharmacodynamics
- 03 Mar 2021 Biomarkers information updated
- 05 Mar 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 02 May 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.